SOPHARMA (SPH): Current report 95 re insiders transactions - raport 95
UNI - EN REPORT No95/2016
Sopharma AD (the “Company”) announces that it was notified by Mr Ognian Donev, Chairman of the Board of Directors that the company ELPHARMA related to him, executed the following transactions related to shares of the Company:
Date and time of settlement Operation Number of shares Unit price (BGN)
29.9.2016 Sale 2 000 2.8480
30.9.2016 Sale 2 371 2.9300
30.9.2016 Sale 2 629 2.9300
30.9.2016 Sale 1 000 2.9450
30.9.2016 Sale 204 2.9450
30.9.2016 Sale 1 500 2.9450
30.9.2016 Sale 296 2.9450
30.9.2016 Sale 2 000 2.9900
3.10.2016 Sale 10 3.0400
3.10.2016 Sale 990 3.0400
3.10.2016 Sale 1 030 3.0550
3.10.2016 Sale 970 3.0550
3.10.2016 Sale 1 000 3.0550
3.10.2016 Sale 1 893 3.0550
3.10.2016 Sale 3 000 2.9700
3.10.2016 Sale 150 2.9700
3.10.2016 Sale 3 400 2.9700
3.10.2016 Sale 1 450 2.9700
3.10.2016 Sale 1 450 2.9700
3.10.2016 Sale 1 550 2.9700
3.10.2016 Sale 3 000 2.9700
3.10.2016 Sale 270 2.9620
3.10.2016 Sale 341 2.9630
3.10.2016 Sale 341 2.9630
3.10.2016 Sale 341 2.9630
3.10.2016 Sale 341 2.9630
3.10.2016 Sale 295 2.9630
3.10.2016 Sale 71 2.9630
4.10.2016 Sale 2 000 2.9600
4.10.2016 Sale 3 400 2.9550
4.10.2016 Sale 240 2.9550
4.10.2016 Sale 306 2.9550
The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade.
